Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk Adapted Treatment for Primary AML in Adults
NCT01716793Phase 2Completed
- Start
- Sep 1998
- Primary completion
- Sep 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cytarabine in acute myeloid leukemia (AML). Started Sep 1998; status: completed.
02
Drugs
cytarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01716793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01716793.